The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis
Open accessAbstract
Mastocytosis is a hematopoietic neoplasm characterized by expansion of KIT D816V-mutated clonal mast cells in various organs and severe or even life-threatening anaphylactic reactions. Recently, hereditary α-tryptasemia (HαT) has been described as a common genetic trait with increased copy numbers of the α-tryptase encoding gene, TPSAB1, and associated with an increased basal serum tryptase level and a risk of mast cell activation. The purpose of our study was to elucidate the clinical relevance of HαT in patients with mastocytosis. TPSAB1 germline copy number variants were assessed by digital polymerase chain reaction in 180 mastocytosis patients, 180 sex-matched control subjects, 720 patients with other myeloid neoplasms, and 61 additional mastocytosis patients of an independent validation cohort. α-Tryptase encoding TPSAB1 copy number gains, compatible with HαT, were identified in 17.2% of mastocytosis patients and 4.4% of the control population (P < .001). Patients with HαT exhibited higher tryptase levels than patients without HαT (median tryptase in HαT+ cases: 49.6 ng/mL vs HαT− cases: 34.5 ng/mL, P = .004) independent of the mast cell burden. Hymenoptera venom hypersensitivity reactions and severe cardiovascular mediator-related symptoms/anaphylaxis were by far more frequently observed in mastocytosis patients with HαT than in those without HαT. Results were confirmed in an independent validation cohort. The high prevalence of HαT in mastocytosis hints at a potential pathogenic role of germline α-tryptase encoding TPSAB1 copy number gains in disease evolution. Together, our data suggest that HαT is a novel emerging robust biomarker in mastocytosis that is useful for determining the individual patient´s risk of developing severe anaphylaxis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is a consensus that HαT is a risk modifier of severe anaphylaxis [21,48,49,50,51,52,53].”
From Diagnostic Significance of Tryptase for Suspected Mast Cell Disorders (2023) · cites this paper as [51]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In patients with systemic mastocytosis (SM), the risk for developing severe or even life-threatening anaphylaxis is high, especially when a concomitant IgE-dependent allergy or the genetic trait Hereditary a -tryptasemia (H a T) is present.”
From Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review (2021) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, an approximately two to three times higher prevalence of H a T has been reported in two large cohorts of SM patients 25,129 ; also, H a T concurrently occurring with MCAS has been reported. 130,131”
From Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review (2021) · cites this paper as [25]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Further, H a T may be associated with an increased severity of anaphylactic reactions and other mediator-induced symptoms in patients with mastocytosis and venom allergy. 25,129”
From Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review (2021) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“in patients with SM, where it can reach up to 12%–20% (17, 19, 22, 23).”
From Defining “Normal” basal serum tryptase levels: a context-dependent approach to improve diagnostics in systemic mastocytosis (2025) · cites this paper as [22]
In the citing paper
“HαT is enriched in patients with SM,42,43 in Hymenoptera-allergic patients with severe anaphylaxis,44,45 and in patients with idiopathic anaphylaxis.42,43,45,46”
From Mast cell activation syndrome: Current understanding and research needs (2024) · cites this paper as [43]
In the citing paper
“Furthermore, MCAS has been reported in patients with hereditary a-tryptasemia (HaT), an autosomal dominant genetic trait caused by an increased copy-number of the atryptase gene TPSAB1, resulting in increased baseline serum tryptase levels.7,8”
From Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders (2024) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
Diagnostic criteria and classification of mastocytosis: a consensus proposal
Valent, P., Horny, H., Escribano, L., Longley, B. J., Li, C. Y., Schwartz, L. B., Marone, G., Núñez, R., Akin, C., Sotlar, K., et al. (2001) · Leukemia Research · doi:10.1016/s0145-2126(01)00038-8 · Cited by 1,114
Self-citationNagata, H., Worobec, A. S., Oh, C. K., Chowdhury, B. A., Tannenbaum, S. H., Suzuki, Y., & Metcalfe, D. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10560 · Cited by 871
Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis
Schwartz, L. B., Metcalfe, D. D., Miller, J. S., Earl, H., & Sullivan, T. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706253162603 · Cited by 784
Valent, P., Akin, C., Escribano, L., Födinger, M., Hartmann, K., Brockow, K., Castells, M., Sperr, W. R., Kluin‐Nelemans, H. C., Hamdy, N. A. T., et al. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01807.x · Cited by 750
Self-citationMastocytosis: 2016 updated WHO classification and novel emerging treatment concepts
Valent, P., Akin, C., & Metcalfe, D. D. (2016) · Blood · doi:10.1182/blood-2016-09-731893 · Cited by 698
Self-citationValent, P., Akin, C., Arock, M., Brockow, K., Butterfield, J. H., Carter, M. C., Castells, M., Escribano, L., Hartmann, K., Lieberman, P., et al. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000328760 · Cited by 654
Self-citationLongley, B. J., Tyrrell, L., Lu, S.-Z., Ma, Y., Langley, K., Ding, T.-G., Duffy, T. P., Jacobs, P., Tang, L. H., & Modlin, I. M. (1996) · Nature Genetics · doi:10.1038/ng0396-312 · Cited by 606
Brockow, K., Jofer, C., Behrendt, H., & Ring, J. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01569.x · Cited by 523
Mast Cells, Mastocytosis, and Related Disorders
Theoharides, T. C., Valent, P., & Akin, C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1409760 · Cited by 518
Self-citation
Cited by
Sorted by citations
Anaphylaxis: A 2023 practice parameter update
Golden, D. B. K., Wang, J., Waserman, S., Akin, C., Campbell, R. L., Ellis, A. K., Greenhawt, M., Lang, D. M., Ledford, D. K., Lieberman, P., et al. (2023) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2023.09.015 · Cited by 392
Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal
Valent, P., Akin, C., Hartmann, K., Alvarez-Twose, I., Brockow, K., Hermine, O., Niedoszytko, M., Schwaab, J., Lyons, J. J., Carter, M. C., et al. (2021) · HemaSphere · doi:10.1097/hs9.0000000000000646 · Cited by 317
Self-citationSystemic mastocytosis in adults: 2021 Update on diagnosis, risk stratification and management
Pardanani, A. D. (2021) · American Journal of Hematology · doi:10.1002/ajh.26118 · Cited by 181
The ingenious mast cell: Contemporary insights into mast cell behavior and function
Dahlin, J. S., Maurer, M., Metcalfe, D. D., Pejler, G., Sagi‐Eisenberg, R., & Nilsson, G. P. (2021) · Allergy · doi:10.1111/all.14881 · Cited by 159
Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines
Risma, K., Edwards, K. M., Hummell, D. S., Little, F. F., Norton, A. E., Stallings, A. P., Wood, R. A., & Milner, J. D. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.04.002 · Cited by 156
Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management
Pardanani, A. (2023) · American Journal of Hematology · doi:10.1002/ajh.26962 · Cited by 132
Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives
Sampath, V., Rabinowitz, G., Shah, M. M., Jain, S., Diamant, Z., Jeseňák, M., Rabin, R. L., Vieths, S., Agache, I. O., Akdiş, M., et al. (2021) · Allergy · doi:10.1111/all.14840 · Cited by 117
Hereditary alpha tryptasemia is not associated with specific clinical phenotypes
Chollet, M. B., & Akin, C. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.06.017 · Cited by 90
Valent, P., Akin, C., Nedoszytko, B., Bonadonna, P., Hartmann, K., Niedoszytko, M., Brockow, K., Siebenhaar, F., Triggiani, M., Arock, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239030 · Cited by 92
Self-citationValent, P., Hartmann, K., Bonadonna, P., Gülen, T., Brockow, K., Alvarez-Twose, I., Hermine, O., Niedoszytko, M., Carter, M. C., Hoermann, G., et al. (2022) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2022.05.007 · Cited by 90
Self-citationDefining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis
Mateja, A., Wang, Q., Chovanec, J., Kim, J., Wilson, K. J., Schwartz, L. B., Glover, S. C., Carter, M. C., Metcalfe, D. D., Brittain, E., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.08.007 · Cited by 91
New Insights into the Pathogenesis of Mastocytosis: Emerging Concepts in Diagnosis and Therapy
Valent, P., Akin, C., Sperr, W. R., Horny, H., Arock, M., Metcalfe, D. D., & Galli, S. J. (2022) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-031521-042618 · Cited by 94
Self-citationGülen, T., Akin, C., Bonadonna, P., Siebenhaar, F., Broesby-Olsen, S., Brockow, K., Niedoszytko, M., Nedoszytko, B., Oude Elberink, H. N. G., Butterfield, J. H., et al. (2021) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2021.06.011 · Cited by 83
“In patients with systemic mastocytosis (SM), the risk for developing severe or even life-threatening anaphylaxis is high, especially when a concomitant IgE-dependent allergy or the genetic trait Hereditary a-tryptasemia (HaT) is present.(22-25) When MCA-related symptoms are severe and recurrent, the diagnosis of MCA s…”
BackgroundSelf-citationGiannetti, M. P., Weller, E., Bormans, C., Novak, P., Hamilton, M. J., & Castells, M. (2021) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2021.01.016 · Cited by 84
Vitte, J., Sabato, V., Tacquard, C., Garvey, L. H., Michel, M., Mertes, P.-M., Ebo, D. G., Schwartz, L. B., & Castells, M. C. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.03.011 · Cited by 79
Valent, P., Hartmann, K., Schwaab, J., Alvarez-Twose, I., Brockow, K., Bonadonna, P., Hermine, O., Niedoszytko, M., Carter, M. C., Hoermann, G., et al. (2022) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2022.03.007 · Cited by 72
Self-citationDiagnosis and treatment of Hymenoptera venom allergy
Ruëff, F., Bauer, A., Becker, S., Brehler, R., Brockow, K., Chaker, A. M., Darsow, U. G., Fischer, J., Fuchs, T., Gerstlauer, M., et al. (2023) · Allergologie select · doi:10.5414/alx02430e · Cited by 72
The Genetic Basis and Clinical Impact of Hereditary Alpha-Tryptasemia
Luskin, K. T., White, A. A., & Lyons, J. J. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.03.005 · Cited by 69
Šelb, J., Rijavec, M., Eržen, R., Zidarn, M., Kopač, P., Škerget, M., Bajrović, N., Luzar, A. D., Park, Y. H., Liu, Y., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.02.043 · Cited by 65
Clinical relevance of inherited genetic differences in human tryptases
Glover, S. C., Carter, M. C., Korošec, P., Bonadonna, P., Schwartz, L. B., Milner, J. D., Caughey, G. H., Metcalfe, D. D., & Lyons, J. J. (2021) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2021.08.009 · Cited by 64
Chovanec, J., Tunc, I., Hughes, J., Halstead, J., Mateja, A., Liu, Y., O’Connell, M. P., Kim, J., Park, Y. H., Wang, Q., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2022007936 · Cited by 62
Mast cell activation syndromes: Collegium Internationale Allergologicum update 2022
Valent, P., Hartmann, K., Bonadonna, P., Niedoszytko, M., Triggiani, M., Arock, M., & Brockow, K. (2022) · International Archives of Allergy and Immunology · doi:10.1159/000524532 · Cited by 55
Self-citationThe international consensus classification of mastocytosis and related entities
Leguit, R. J., Wang, S. A., George, T. I., Tzankov, A., & Orazi, A. (2023) · Virchows Archiv · doi:10.1007/s00428-022-03423-3 · Cited by 65
Anaphylaxis and Mast Cell Disorders
Gülen, T., & Akin, C. (2022) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2021.09.007 · Cited by 51
Sprinzl, B., Greiner, G., Uyanik, G., Arock, M., Haferlach, T., Sperr, W. R., Valent, P., & Hoermann, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052458 · Cited by 51
Self-citationInherited and acquired determinants of serum tryptase levels in humans
Lyons, J. J. (2021) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2021.06.019 · Cited by 52
Mast cell tryptases in allergic inflammation and immediate hypersensitivity
Lyons, J. J., & Yi, T. (2021) · Current Opinion in Immunology · doi:10.1016/j.coi.2021.04.001 · Cited by 55
Sordi, B., Vanderwert, F., Crupi, F., Gesullo, F., Zanotti, R., Bonadonna, P., Crosera, L., Elena, C., Fiorelli, N., Ferrari, J., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.09.038 · Cited by 51
Incorporating Tryptase Genotyping Into the Workup and Diagnosis of Mast Cell Diseases and Reactions
Lyons, J. J., Greiner, G., Hoermann, G., & Metcalfe, D. D. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.05.003 · Cited by 50
Self-citationMediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis
Brockow, K., Plata‐Nazar, K., Lange, M., Nedoszytko, B., Niedoszytko, M., & Valent, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052684 · Cited by 52
Self-citationElevated Basal Serum Tryptase: Disease Distribution and Variability in a Regional Health System
Waters, A. M., Park, H. J., Weskamp, A. L., Mateja, A., Kachur, M. E., Lyons, J. J., Rosen, B. J., & Boggs, N. A. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.12.031 · Cited by 46
Giannetti, M. P., Akin, C., Hufdhi, R., Hamilton, M. J., Weller, E., van Anrooij, B., Lyons, J. J., Hornick, J. L., Pinkus, G., Castells, M., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.11.017 · Cited by 43
Hereditary alpha-tryptasemia: a commonly inherited modifier of anaphylaxis
Wu, R., & Lyons, J. J. (2021) · Current Allergy and Asthma Reports · doi:10.1007/s11882-021-01010-1 · Cited by 43
Arock, M., Hoermann, G., Sotlar, K., Hermine, O., Sperr, W. R., Hartmann, K., Brockow, K., Akin, C., Triggiani, M., Broesby‐Olsen, S., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.04.004 · Cited by 42
Self-citationMast cell activation syndrome: Current understanding and research needs
Castells, M., Giannetti, M. P., Hamilton, M. J., Novak, P., Pozdnyakova, O., Nicoloro-SantaBarbara, J., Jennings, S. V., Francomano, C., Kim, B., Glover, S. C., et al. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2024.05.025 · Cited by 45
Self-citationGonzález‐de‐Olano, D., Navarro‐Navarro, P., Muñoz‐González, J. I., Sánchez‐Muñoz, L., Henriques, A., de‐Andrés‐Martín, A., Peralta‐Arjonilla, D., Mayado, A., Jara‐Acevedo, M., García‐Montero, A. C., et al. (2024) · Allergy · doi:10.1111/all.15911 · Cited by 38
Clonal mast cell disorders and hereditary α-tryptasemia as risk factors for anaphylaxis
Kačar, M., Rijavec, M., Šelb, J., & Korošec, P. (2023) · Clinical & Experimental Allergy · doi:10.1111/cea.14264 · Cited by 37
Valent, P., Hartmann, K., Hoermann, G., Reiter, A., Álvarez‐Twöse, I., Brockow, K., Bonadonna, P., Hermine, O., Niedoszytko, M., Carter, M. C., et al. (2024) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2024.08.044 · Cited by 42
Self-citationPolivka, L., Madrange, M., Livideanu, C. B., Barète, S., Ballul, T., Neuraz, A., Greco, C., Agopian, J., Brenet, F. A., Dubreuil, P. C., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.08.015 · Cited by 37
Korošec, P., Sturm, G. J., Lyons, J. J., Marolt, T. P., Svetina, M., Košnik, M., Zidarn, M., Kačar, M., Frelih, N., Lalek, N., et al. (2024) · Allergy · doi:10.1111/all.16084 · Cited by 40
Clinical Impact of Inherited and Acquired Genetic Variants in Mastocytosis
Nedoszytko, B., Arock, M., Lyons, J. J., Bachelot, G., Schwartz, L. B., Reiter, A., Jawhar, M., Schwaab, J., Lange, M., Greiner, G., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010411 · Cited by 37
Self-citationResponse Criteria in Advanced Systemic Mastocytosis: Evolution in the Era of KIT Inhibitors
Shomali, W. E., & Gotlib, J. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062983 · Cited by 37
World Health Organization Classification and Diagnosis of Mastocytosis
Valent, P., Sotlar, K., Horny, H., Arock, M., & Akin, C. (2023) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2023.04.011 · Cited by 37
Self-citationThe Role of Mast Cells in the Induction and Maintenance of Inflammation in Selected Skin Diseases
Woźniak, E., Owczarczyk-Saczonek, A. B., Lange, M., Czarny, J. H., Wygonowska, E., Placek, W. J., & Nedoszytko, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087021 · Cited by 36
Self-citationIdiopathic Anaphylaxis: a Perplexing Diagnostic Challenge for Allergists
Gülen, T., & Akin, C. (2021) · Current Allergy and Asthma Reports · doi:10.1007/s11882-021-00988-y · Cited by 35
Severe food allergy reactions are associated with α-tryptase
Lang, A., Kubala, S., Grieco, M. C., Mateja, A., Pongracic, J., Liu, Y., Frischmeyer-Guerrerio, P. A., Kumar, R., & Lyons, J. J. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.07.014 · Cited by 36
Tryptase in type I hypersensitivity
Michel, M., Klingebiel, C., & Vitte, J. (2022) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2022.08.996 · Cited by 34
Konnikova, L., Robinson, T. O., Owings, A. H., Shirley, J. F., Davis, E. M., Tang, Y., Wall, S. M., Li, J., Hasan, M., Gharaibeh, R. Z., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.04.004 · Cited by 30
Review and updates on systemic mastocytosis and related entities
Li, J. Y., Ryder, C. B., Zhang, H., Cockey, S. G., Hyjek, E., Moscinski, L. C., Sagatys, E., & Song, J. (2023) · Cancers · doi:10.3390/cancers15235626 · Cited by 31
Rama, T. A., Morgado, J. M., Henriques, A., Escribano, L., Álvarez‐Twöse, I., Sánchez‐Muñoz, L., Moreira, A. M., Romão, J., Órfão, A., & Matito, A. (2022) · Clinical and Translational Allergy · doi:10.1002/clt2.12132 · Cited by 29
Akin, C., Arock, M., Carter, M. C., George, T. I., & Valent, P. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00611-8 · Cited by 31
Self-citationSystemic Mastocytosis and Other Entities Involving Mast Cells: A Practical Review and Update
Hussein, S. E., Chifotides, H. T., Khoury, J. D., Verstovšek, S., & Thakral, B. (2022) · Cancers · doi:10.3390/cancers14143474 · Cited by 30
(2023) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2023.07.001 · Cited by 25
Self-citationSecretory and Membrane-Associated Biomarkers of Mast Cell Activation and Proliferation
Parente, R., Giudice, V., Cardamone, C., Serio, B., Selleri, C., & Triggiani, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087071 · Cited by 26
Alpha-tryptase as a risk-modifying factor for mast cell–mediated reactions
Shin, H., & Lyons, J. J. (2024) · Current Allergy and Asthma Reports · doi:10.1007/s11882-024-01136-y · Cited by 24
Bone Marrow Mastocytosis: A Diagnostic Challenge
Zanotti, R., Tanasi, I., Bernardelli, A., Orsolini, G., & Bonadonna, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071420 · Cited by 24
Zaghmout, T., Maclachlan, L., Bedi, N., & Gülen, T. (2024) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2023.11.041 · Cited by 23
Gotlib, J. R., Schwaab, J., Shomali, W. E., George, T. I., Radia, D. H., Castells, M., Carter, M. C., Hartmann, K., Álvarez‐Twöse, I., Brockow, K., et al. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.05.034 · Cited by 24
Self-citationA Puzzling Mast Cell Trilogy: Anaphylaxis, MCAS, and Mastocytosis
Gülen, T. (2023) · Diagnostics · doi:10.3390/diagnostics13213307 · Cited by 21
Rama, T. A., Torrado, I., Henriques, A. F., Sánchez-Muñoz, L., Jara-Acevedo, M., Navarro-Navarro, P., Caldas, C., Mayado, A., Muñoz-González, J., García-Montero, A., et al. (2023) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2022.11.042 · Cited by 20
Diagnostic Significance of Tryptase for Suspected Mast Cell Disorders
Beyens, M., Toscano, A., Ebo, D., Gülen, T., & Sabato, V. (2023) · Diagnostics · doi:10.3390/diagnostics13243662 · Cited by 22
O’Connell, M. P., & Lyons, J. J. (2022) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000813 · Cited by 19
Pühringer, V., Jilma, B., & Herkner, H. (2023) · Frontiers in Allergy · doi:10.3389/falgy.2023.1249280 · Cited by 21
Using the Right Criteria for MCAS
Gülen, T. (2024) · Current Allergy and Asthma Reports · doi:10.1007/s11882-024-01126-0 · Cited by 22
Bonadonna, P., Nalin, F., & Olivieri, F. (2022) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/aci.0000000000000849 · Cited by 18
New Insights into the Pathogenesis of Systemic Mastocytosis
Li, Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094900 · Cited by 19
Extrinsic and Intrinsic Modulators of Anaphylaxis
Carter, M. C., Park, J., Vadas, P., & Worm, M. (2023) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.05.015 · Cited by 17
How to evaluate the patient with a suspected mast cell disorder and how/when to manage symptoms
Akin, C. (2022) · Hematology · doi:10.1182/hematology.2022000366 · Cited by 19
The clinical features of hereditary alpha-tryptasemia
von Bubnoff, D., Koch, D., Stocker, H. R., Ludwig, R. J., Wortmann, F., & von Bubnoff, N. C. C. (2024) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2023.0287 · Cited by 17
On the complexities of tryptase genetics and impact on clinical phenotypes
Lyons, J. J. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.08.011 · Cited by 16
Current Challenges in the Diagnosis of Pediatric Cutaneous Mastocytosis
Ługowska‐Umer, H., Czarny, J. H., Rydz, A., Nowicki, R. J., & Lange, M. (2023) · Diagnostics · doi:10.3390/diagnostics13233583 · Cited by 15
Akin, C., Siebenhaar, F., Wechsler, J. B., Youngblood, B. A., & Maurer, M. (2024) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2024.03.010 · Cited by 18
Hereditary α-tryptasemia is Associated With Anaphylaxis to Antibiotics and Monoclonal Antibodies
Korošec, P., Lyons, J. J., Svetina, M., Koudová, M., Bittóova, M., Zidarn, M., Sedláčková, L., Rijavec, M., & Kopač, P. (2025) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2025.04.013 · Cited by 16
Rama, T. A., & Castells, M. (2023) · Current Treatment Options in Allergy · doi:10.1007/s40521-023-00349-2 · Cited by 15
Risk Factors for Severe Sting Reactions and Side Effects During Venom Immunotherapy
Sturm, G. J., Schadelbauer, E., Marta, G., Bonadonna, P., & Košnik, M. (2024) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2024.08.025 · Cited by 14
Gotlib, J. R., George, T. I., Carter, M. C., Austen, K. F., Bochner, B. S., Dwyer, D. F., Lyons, J. J., Hamilton, M. J., Butterfield, J. H., Bonadonna, P., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.03.008 · Cited by 14
Self-citationHαT is associated with increased risk for severe Hymenoptera venom–triggered anaphylaxis
Šelb, J., Rijavec, M., Kopač, P., Lyons, J. J., & Korošec, P. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.11.017 · Cited by 14
Systemic mastocytosis: 2023 update on diagnosis and management in adults
Costa, A. N., Scalzulli, E., Carmosino, I., Capriata, M., Ielo, C., Masucci, C., Passucci, M., Martelli, M., & Breccia, M. (2023) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2023.2221028 · Cited by 13
Valent, P., Akin, C., & Arock, M. (2024) · Current Allergy and Asthma Reports · doi:10.1007/s11882-024-01124-2 · Cited by 13
Self-citationDiagnostic Utility of Biomarkers in Anaphylaxis: A Systematic Review and Meta-Analysis
Khalaf, R., Prosty, C. J., Davalan, W., Abrams, E. M., Kaouache, M., & Ben‐Shoshan, M. (2025) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2025.04.008 · Cited by 15
Hypertryptasemia and Mast Cell-Related Disorders in Severe Osteoporotic Patients
Carosi, G., Guabello, G., Longhi, M., Grifoni, F. I., Passeri, E., & Corbetta, S. (2020) · Mediators of Inflammation · doi:10.1155/2020/5785378 · Cited by 13
Vazquez, M., Chovanec, J. F., Kim, J., DiMaggio, T., Milner, J. D., Francomano, C. A., Gurnett, C. A., Ritelli, M., Colombi, M., & Lyons, J. J. (2022) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2022.100094 · Cited by 13
Management of Mediator Symptoms, Allergy, and Anaphylaxis in Mastocytosis
Gülen, T. (2023) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2023.04.010 · Cited by 14
Mastocytosis and related entities: A practical roadmap
Beyens, M., Elst, J., van der Poorten, M.-L., Van Gasse, A., Toscano, A., Verlinden, A., Vermeulen, K., Maes, M.-B., Oude Elberink, J. N. G. H., Ebo, D., et al. (2023) · Acta Clinica Belgica · doi:10.1080/17843286.2022.2137631 · Cited by 13
Underlying systemic mastocytosis in patients with unexplained osteoporosis: score proposal
Tanasi, I., Crosera, L., Taus, F., Orsolini, G., Adami, G., Olivieri, F., Bernardelli, A., Bonadonna, P., Nalin, F., Sella, S., et al. (2024) · Bone · doi:10.1016/j.bone.2024.117141 · Cited by 12
Jennings, S. V., Finnerty, C. C., Hobart, J. S., Martín‐Martinez, M., Sinclair, K. A., Slee, V. M., Agopian, J., Akin, C., Álvarez‐Twöse, I., Bonadonna, P., et al. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.06.018 · Cited by 13
Self-citationMcMurray, J. C., Pacheco, C. S., Schornack, B. J., Sun, X., Brunader, J. A., Scott, A. E., Ariza, J. S., Kou, C.-T. J., Costantino, R. C., Pittman, L. M., et al. (2024) · Blood · doi:10.1182/blood.2023023347 · Cited by 11
Challenges in Drug and Hymenoptera Venom Hypersensitivity Diagnosis and Management in Mastocytosis
Giannetti, M. P., Nicoloro‐SantaBarbara, J. M., Godwin, G., Middlesworth, J., Espeland, A., Douvas, J. L., & Castells, M. (2024) · Diagnostics · doi:10.3390/diagnostics14020123 · Cited by 11
Clinically accessible amplitude-based multiplex ddPCR assay for tryptase genotyping
Svetina, M., Šelb, J., Lyons, J. J., Korošec, P., & Rijavec, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-52983-8 · Cited by 13
Anaphylaxis: Advances in the Past 10 Years
Weiler, C. R., Schrijvers, R., & Golden, D. B. K. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.09.019 · Cited by 13
A Challenge for Allergologist: Application of Allergy Diagnostic Methods in Mast Cell Disorders
Romantowski, J., Górska, A., Niedoszytko, M., Gülen, T., Gruchała‐Niedoszytko, M., Nedoszytko, B., Lange, M., Brockow, K., Arock, M., Akin, C., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031454 · Cited by 11
Self-citationState-of-the-Art on Biomarkers for Anaphylaxis in Obstetrics
SIMIONESCU, A. A., Stănescu, A. M. A., & Popescu, F. (2021) · Life · doi:10.3390/life11090870 · Cited by 11
Valent, P., Arock, M., Akin, C., & Metcalfe, D. D. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.04.041 · Cited by 11
Self-citationDefining hereditary alpha-tryptasemia as a risk/modifying factor for anaphylaxis: Are we there yet?
Couto, M. L., Silva, M., Barbosa, M. J., Ferreira, F., Fragoso, A. S., & Azenha Rama, T. (2023) · European Annals of Allergy and Clinical Immunology · doi:10.23822/eurannaci.1764-1489.288 · Cited by 10
Genetic Changes in Mastocytes and Their Significance in Mast Cell Tumor Prognosis and Treatment
Zmorzyński, S., Kimicka-Szajwaj, A., Szajwaj, A., Czerwik-Marcinkowska, J., & Wojcierowski, J. (2024) · Genes · doi:10.3390/genes15010137 · Cited by 9
Chatain, C., Sedillot, N., Thomas, M., Pernollet, M., Bocquet, A., Boccon‐Gibod, I., Bouillet, L., & Leccia, M. ‐. (2021) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2021.08.005 · Cited by 9
What the clinician should know when ordering a mast cell tryptase test
Michel, M., Giusti, D., Klingebiel, C., Pham, B., & Vitte, J. (2025) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2025.03.003 · Cited by 9
Expanding the Immunologic and Neuronal Landscape of IgE‐Mediated Anaphylaxis
Biswas, R., Fried, J. M., & de Lafaille, M. A. C. (2025) · Immunological Reviews · doi:10.1111/imr.70078 · Cited by 8
Tryptase and tumor angiogenesis
Ribatti, D. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1500482 · Cited by 9
Genetic Variants Leading to Urticaria and Angioedema and Associated Biomarkers
Lyons, J. J., Farkas, H., Germenis, A. E., Rijavec, M., Smith, T., & Valent, P. (2023) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.05.031 · Cited by 11
Self-citation
Metadata
- Authors
- Greiner, G., Sprinzl, B., Górska, A., Ratzinger, F., Gurbisz, M., Witzeneder, N., Schmetterer, K. G., Gisslinger, B., Uyanik, G., Hadzijusufovic, E., Esterbauer, H., Gleixner, K. V., Krauth, M. T., Pfeilstöcker, M., Keil, F., Gisslinger, H., Nedoszytko, B., Niedoszytko, M., Sperr, W. R., Valent, P., & Hoermann, G.
- Affiliations
- Ludwig Boltzmann Institute for Hematology and Oncology (AT)
- Hanusch Hospital (AT)
- Gdańsk Medical University (PL)
- Ihr Labor, Medical Diagnostic Laboratories, Vienna, Austria;
- Medical University of Vienna (AT)
- Sigmund Freud Privatuniversität Wien (AT)
- University of Veterinary Medicine Vienna (AT)
- Department of Dermatology, Medical University of Gdańsk, Gdańsk, Poland;
- Innsbruck Medical University (AT)
- Corresponding author
- Hoermann, Gregor
- ORCID
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2021-01-14
- Volume
- 137
- Issue
- 2
- Pages
- 238-247
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC7116780
- OpenAlex
- W3048592971
- Cited by
- 189
- References
- 59
- Citations by year
- 2026: 24 · 2025: 31 · 2024: 28 · 2023: 29 · 2022: 33 · 2021: 40
- FWCI
- 9.18
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal Tumor Research and Treatment
- Health Sciences › Medicine › Surgery › Congenital gastrointestinal and neural anomalies
- Keywords
- hereditary alpha-tryptasemia, mastocytosis, TPSAB1, copy number gain, genetic biomarkers, anaphylaxis, KIT D816V mutation, mast cell activation, myeloid neoplasms
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Female, Genetic Markers, Humans, Male, Mastocytosis, Middle Aged, Tryptases, Young Adult, DNA Copy Number Variations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
